|  | Univariable | Multivariable* | ||
---|---|---|---|---|---|
Marker | Antiretrovirals | Mean fold change percentage difference (95% CI) | P value | Mean fold change percentage difference (95% CI) | P value |
IL-6 | TDF/FTC | Ref. | Â | Â | Â |
ABC/3TC | 1 (-67 to 41) | 0.97 | 4 (-80 to 49) | 0.90 | |
EFV | Ref. | Â | Â | Â | |
ATV/r | -39 (-120 to 12) | 0.16 | -20 (-101 to 28) | 0.48 | |
LPV/r | 38 (-8 to 63) | 0.09 | 43 (-23 to 74) | 0.15 | |
hs-CRP | TDF/FTC | Ref. | Â | Â | Â |
ABC/3TC | 18 (-77 to 62) | 0.60 | 7 (-155 to 66) | 0.88 | |
EFV | Ref. | Â | Â | Â | |
ATV/r | -16 (-139 to 43) | 0.68 | -34 (-203 to 41) | 0.47 | |
LPV/r | 16 (-97 to 63) | 0.67 | 41 (-29 to 82) | 0.39 | |
sCD14 | TDF/FTC | Ref. | Â | Â | Â |
ABC/3TC | 7 (-13 to 3) | 0.48 | 14 (-8 to 31) | 0.18 | |
EFV | Ref. | Â | Â | Â | |
ATV/r | -14 (-36 to 4) | 0.13 | -19 (-43 to 1) | 0.06 | |
LPV/r | -6 (-31 to 14) | 0.57 | -4 (-36 to 21) | 0.77 | |
IP10 | TDF/FTC | Ref. | Â | Â | Â |
ABC/3TC | 16 (-22 to 42) | 0.36 | 30 (-6 to 54) | 0.09 | |
EFV | Ref. | Â | Â | Â | |
ATV/r | -55 (-118 to -12) | 0.01 | -57 (-120 to -11) | 0.011 | |
LPV/r | -26 (-92 to 17) | 0.27 | -4 (-80 to 39) | 0.87 | |
MIG | TDF/FTC | Ref. | Â | Â | Â |
ABC/3TC | -8 (-103 to 42) | 0.80 | 24 (-62 to 65) | 0.47 | |
EFV | Ref. | Â | Â | Â | |
ATV/r | -146 (-306 to -45) | 0.001 | -136 (-339 to -27) | 0.007 | |
 | LPV/r | -151 (-395 to -31) | 0.006 | -48 (-297 to 45) | 0.44 |